Piramal Health - Piramal Healthcare to present Phase I data for oral anticancer molecule at the American Society for Clinical Oncology (ASCO) Annual Meeting

MARKET RADAR

SENSEX NIFTY Refresh

YOU ARE HERE > Moneycontrol > Markets > Announcements > Pharmaceuticals > Announcement - Piramal Enter

Piramal Enter

BSE: 500302

NSE: PEL

ISIN: INE140A01024

22nd-May-2012 11:10Source: BSE

Piramal Health - Piramal Healthcare to present Phase I data for oral anticancer molecule at the American Society for Clinical Oncology (ASCO) Annual Meeting

Piramal Healthcare Ltd has informed BSE regarding a Press Release dated May 22, 2012 titled "Piramal Healthcare to present Phase I data for oral anticancer molecule at the American Society for Clinical Oncology (ASCO) Annual Meeting"

More Announcements on:

17th-May-2013 08:58Source: NSE

Piramal Enterprises Limited

16th-May-2013 18:09Source: BSE

Piramal Enter - Updates on Scheme of Amalgamation and Arrangement

16th-May-2013 10:53Source: NSE

Piramal Enterprises Limited

15th-May-2013 17:58Source: BSE

Piramal Enter - Updates on Press Release dated May 10, 2013

10th-May-2013 12:16Source: BSE

Piramal Enter - Piramal Enterprises Limited acquires ~ 10% Equity Stake in Shriram Transport Finance Company Limited

10th-May-2013 12:10Source: BSE